Дмитрий Окишев - Хирургическое лечение каверном полушарий большого мозга. Анализ ближайших и отдаленных результатов лечения

28. Cohen D. S., Zubay G. P., Goodman R. R. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83: 237—242, 1995.

29. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22: 4898—501, 1981.

30. Cosgrove G. R. Occult vascular malformations and seizures. Neurosurg Clin N Am 10: 527—535, 1999.

31. Craig H. D., Günel M., Cepeda O., Johnson E. W., Ptacek L., Steinberg G. K. et al: Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7. P. 15—13 and 3q25. 2—27. Hum Mol Genet 7: 1851—1858, 1998.

32. Dandy W. E. Venous abnormalities and angiomas of the brain. Arch Surg 17: 715—793, 1928.

33. de Souza J. M., Domingues R. C., Cruz L. C. Jr. et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol. 2008 Jan; 29 (1): 154—8. Epub 2007 Oct 18.

34. Deistung A., Rauscher A., Sedlacik J. et al. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med. 2008 Nov; 60 (5): 1155—68.

35. Del Curling O., Kelly D. L., Elster A. D., Craven T. E. An analysis of the natural history of cavernous angiomas. J Neurosurg. 1991; 75 (5): 702—708.

36. Devinski O. Seizure diksorders. Clinical symposia, 1994. — V. 41. — P. 1—33.

37. Dubovsky J., Zabramski J. M., Kurth J., Spetzler R. F., Rich S. S., Orr H. T. et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 4: 453—458, 1995.

38. Engel J. Jr., Van Ness P. C., Rasmussen T. B., Ojemann L. M. Outcome with respect to epileptic seizures, in Engel J Jr (ed): Surgical Treatment of the Epilepsies. — N. Y.: Raven Press, 1993. Ed 2. — Pp. 609—622.

39. Engel J. Jr. A Proposed Diagnostic Scheme for people with Epileptic Seizures and with Epilepsy. Report of the ILAE Task Force on Classification and terminology. Epilepsia 42: 796—803, 2001.

40. Er U., Spetzler R. F., Cardia A., Lanzino G., Deep-Seated Cerebral Cavernous Malformations. In: Lanzino G, ed., Spetzler RF, ed. Cavernous Malformations of the Brain and Spinal Cord. Thieme; 2007: 71—77.

41. Estes M. L., Morris H. Hr., Luders H. et al. Surgery for intractable epilepsy. Clinicopathologic correlates in 60 cases. Cleveland Clinic Journal of Medicine 55: 441 —447, 1998.

42. Ferrier C. H., Aronica E., Leijten F. S. et al. Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy. J Neurosurg. 2007 Sep;107 (3): 495—503.

43. Flemming K. D., Goodman B. P., Meyer F. B. Successful brainstem cavernous malformation resection after repeated hemorrhages during pregnancy. Surg Neurol. 2003 Dec; 60 (6): 545—7; discussion 547—8.

44. Folkersma H., Mooij J. J. Follow-up of 13 patients with surgical treatment of cerebral cavernous malformations: effect on epilepsy and patient disability. Clin Neurol Neurosurg 103: 67—71, 2001.

45. Frerich K. U., Stieg P. E., Friedlander R. M. Classification and Grading Systems. Stieg P. E., Batjer H. H., Samson D. (eds): Intracranial Arteriovenous Malformations. N. Y.: Informa Healthcare, 2007.

46. Garner T. B., Del Curling O. Jr., Kelly D. L. Jr., Laster D. W. The natural history of intracranial venous angiomas. J Neurosurg. 1991 Nov; 75 (5): 715—22.

47. Gil-Nagel A., Dubovsky J., Wilcox K. J., Stewart J. M., Anderson V. E., Leppik I. E. et al: Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q. Ann Neurol 39: 807—810, 1996.

48. Gralla J., Ganslandt O., Kober H. et al. Image-guided removal of supratentorial cavernomas in critical brain areas: application of neuronavigation and intraoperative magnetic resonance imaging. Minim Invasive Neurosurg. 2003 Apr; 46 (2): 72—7.

49. Gross B. A., Batjer H. H., Awad I. A., Bendok B. R. Cavernous malformations of the basal ganglia and thalamus. Neurosurgery. 2009 Jul; 65 (1): 7—18; discussion 18—9.

50. Gross B. A., Lin N., Du R., Day A. L. The natural history of intracranial cavernous malformations. Neurosurg Focus. 2011 Jun; 30 (6): E24.

51. Günel M., Awad I. A., Finberg K., Anson J. A., Steinberg G. K., Batjer H. H. et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 334: 946—951, 1996.

52. Gunel M., Laurans M. S., Shin D. et al. KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. ProcNatl Acad Sci USA 99: 10677—10682, 2002.

53. Hayman L. A., Evans R. A., Ferrell R. E. et al: Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am j Med Genet 11: 147—160, 1982.

54. Heffez D. S. Stereotactic transsylvian, transinsular approach for deep-seated lesions. Surg Neurol. 1997 Aug; 48 (2): 113—24.

55. Heros R. C., Ojemann R. G., Crowell R. M. Superior temporal gyrus approach to middle cerebral artery aneurysms: technique and results. Neurosurgery. 1982 Mar; 10 (3): 308—13.

56. Huo L., Wu L., Zhang M. Y. et al. Electrocorticography monitoring in microsurgical treatment of solitary cavernous angiomas. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 May; 33 (5): 448—51.

57. Johnson E. W. Cerebral cavernous malformation, familial. http://www.ncbi.nlm.nih.gov/books/NBK1293/

58. Jung K. H., Chu K., Jeong S. W. et al. Cerebral cavernous malformations with dynamic and progressive course. Correlation study with vascular endothelial growth factor. Arch Neurol 60: 1613—1618, 2003.

59. Kahane P., Munari C., Hoffmann D. et al. Approche chirurgicale multimodale des angiomes caverneux epileptogenes. Epilepsies 6: 113—130, 1994.

60. Kamezawa T., Hamada J., Niiro M. et al. Clinical implications of associated venous drainage in patients with cavernous malformation. J Neurosurg. 2005 Jan; 102 (1): 24—8.

61. Kattapong V. J., Hart B. L., Davis L. E. Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology. 1995 Mar; 45 (3 Pt 1): 492—7.

62. Kilic T., Pamir M. N., Kullu S. et al. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46: 1179—1192, 2000.

63. Kim D. S., Park Y. G., Choi J. U., Chung S. S., Lee K. C. An analysis cerebral cavernous angiomas. Neurosurgery 38: 662—670, 1996.

64. Kivelev J., Niemelä M., Blomstedt G. et al. Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien). 2011 Feb; 153 (2): 261—70. Epub 2010. Sep 26.

65. Kivelev J., Niemelä M., Kivisaari R. et al. Long-term outcome of patients with multiple cerebral cavernous malformations. Neurosurgery. 2009 Sep; 65 (3): 450—5; discussion 455.

66. Kivelev J., Niemelä M., Kivisaari R., Hernesniemi J. Intraventricular cerebral cavernomas: a series of 12 patients and review of the literature. J Neurosurg. 2010 Jan; 112 (1): 140—9.

67. Kondziolka D., Lunsford L. D., Kestle J. R. The natural history of cerebral cavernous malformations. J Neurosurg 83: 820—824, 1995.

68. Kraemer D. K. A., Pizzonia J. H. How do vascular lesions cause epilepsy? In Kotagal P., Lüders H. O. (eds): The Epilepsies, Etiology and Prevention. N. Y.: Raven Press, 1999. — Pp. 385—390.

69. Kraemer D. L., Awad I. A. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia 35 Suppl 6. — 1994. — S. 30—43.

70. Kufs H. Uber heredofmiliare Angiomatose des Gehirns und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Gesamste Neurol Psychiatr 113: 651—686, 1928.